Depression Care Management for Depressed Elders in China Primary Care (DCM)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01287494|
Recruitment Status : Unknown
Verified January 2011 by Zhejiang University.
Recruitment status was: Recruiting
First Posted : February 1, 2011
Last Update Posted : February 1, 2011
|Condition or disease||Intervention/treatment||Phase|
|Depression||Drug: Sertraline||Phase 4|
- At the patient level: The investigator will gather information about age, gender, education, marital status, living conditions and satisfaction with their economic status, as well as systematic information on suicidal ideation,, psychopathology, medical health, cognitive function, quality of life and stigma and satisfaction for the treatment.
- At the provider level: the objective of research measures at the provider level is to gather social-demographic data such as age, gender, education, marital status, clinical experience among physicians in the participating PCCs as well as systematic information on their attitudes/knowledge regarding depression and clinical practices with the treatment guidelines.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||320 participants|
|Intervention Model:||Factorial Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Official Title:||Collaborative Care for Depressed Elders in China|
|Study Start Date :||August 2010|
|Estimated Primary Completion Date :||February 2014|
|Estimated Study Completion Date :||July 2014|
Experimental: Depression Care Management
DCM Intervention for Depressed Elders in Primary Care
dosage form: Capsule dosage: 50-200mg/d frequency: once per day duration: 16 weeks
Other Name: Zoloft
|No Intervention: Care as Usual|
- the DCM intervention results in improved outcomes compared with CAU at both the provider (e.g., greater adherence to quality indicators) and patient levels (e.g., greater reduction in depressive symptoms) [ Time Frame: 16 weeks ]16 weeks treatment with Sertraline and following up 2 years
- compare DCM with CAU with regard to a range of outcomes in other pertinent domains, both at the provider (e.g., improvements in knowledge/attitudes) and patient (e.g., functioning, satisfaction) levels [ Time Frame: 28 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01287494
|Contact: Shulin Chen, MD&PhDfirstname.lastname@example.org|
|Study Director:||Ju Zhang, PhD||Zhejiang University|